Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy
- 1 February 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 188 (2) , 454-460
- https://doi.org/10.1067/mob.2003.14
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosusClinical and Experimental Immunology, 2001
- Normal Expression of Cell Adhesion Molecules in Placentae from Women with Systemic Lupus Erythematosus and the Antiphospholipid SyndromePlacenta, 2000
- Systemic Endothelial Cell Markers in Primary Antiphospholipid SyndromeThrombosis and Haemostasis, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In VivoCirculation, 1999
- Activation of cultured vascular endothelial cells by antiphospholipid antibodies.Journal of Clinical Investigation, 1995
- Criteria for the Diagnosis of Lupus Anticoagulants: An UpdateThrombosis and Haemostasis, 1995
- Customised antenatal growth chartsThe Lancet, 1992
- The classification and definition of the hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology, 1988
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986